# US 2024/0198344 A1 · Blood container and manufacturing method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0198344 A1
- Document ID: US20240198344A1
- Status: Published application
- Kind: A1
- Application number: 18/299,720
- Filed: 2023-04-13
- Published: 2024-06-20
- Earliest claimed: 2022-12-15
- Assignees: Nan Ya Plastics Corporation
- Applicants: Nan Ya Plastics Corporation
- Inventors: TE-CHAO LIAO; Min-Fan Chung; CHING-YAO YUAN; CHIA-JUNG CHANG
- Web page: https://patentgrep.com/patent/US20240198344A1

## CPC

- B01L 3/5082: {Test tubes per se}
- B01L 3/50825: {Closing or opening means, corks, bungs}
- A01N 1/146: Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
- B01L 2200/12: Specific details about manufacturing devices
- B01L 2200/14: Process control and prevention of errors
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/042: Caps; Plugs
- B01L 2300/16: Surface properties and coatings
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS

## Abstract

A blood container and a method for manufacturing the same are provided. The blood container includes a container body and an anti-fouling layer to be hydrated. The container body has an inner wall surface, and the anti-fouling layer to be hydrated covers the inner wall surface and contains a hydration polymer. A covering rate of the hydration polymer on the inner wall surface is from 50% to 100%.

## Claims

### Claim 1

A blood container, comprising:
a container body having an inner wall surface;
an anti-fouling layer to be hydrated covering the inner wall surface and containing a hydration polymer;
wherein a covering rate of the hydration polymer on the inner wall surface is from 50% to 100%.

### Claim 2 (depends on 1)

The blood container according to claim 1, wherein a thickness of the anti-fouling layer to be hydrated ranges from 5 μm to 100 μm.

### Claim 3 (depends on 2)

The blood container according to claim 2, wherein the hydration polymer is a zwitterionic polymer, one molecular end of the zwitterionic polymer has an acrylate group, and another molecular end of the zwitterionic polymer has an anionic moiety or a cationic moiety.

### Claim 4 (depends on 3)

The blood container according to claim 3, wherein the anti-fouling layer that is hydrated has a hydrous layer formed thereon.

### Claim 5 (depends on 3)

The blood container according to claim 3, wherein a number average molecular weight of the zwitterionic polymer ranges from 5000 g/mol to 10000 g/mol.

### Claim 6 (depends on 3)

The blood container according to claim 3, wherein the anionic moiety of the zwitterionic polymer is selected from the group consisting of a phosphate group, a sulfonic acid group, and a carboxylic acid group, and the cationic moiety of the zwitterionic polymer is a quaternary ammonium group.

### Claim 7 (depends on 3)

The blood container according to claim 3, wherein the zwitterionic polymer includes 2-methacryloyloxyethylphosphoric choline, sulfobetaine methacrylate, carboxybetaine methyl methacrylate, or any combination thereof.

### Claim 8

A method for manufacturing a blood container, comprising:
providing a container body that has an inner wall surface; and
treating the container body with a treatment solution including a hydration polymer, such that an anti-fouling layer to be hydrated is formed on the inner wall surface and contains the hydration polymer;
wherein a covering rate of the hydration polymer on the inner wall surface is from 50% to 100%.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the treatment solution includes water, and based on a total weight of the treatment solution being 100 wt %, an amount of the hydration polymer is from 0.5 wt % to 5 wt %.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the treatment solution further includes a highly volatile solvent, and based on the total weight of the treatment solution being 100 wt %, an amount of the highly volatile solvent is from 50 wt % to 99 wt %.

### Claim 11 (depends on 9)

The method according to claim 9, wherein in the step of treating the container body with the treatment solution, the container body is immersed in the treatment solution for 10 seconds to 60 seconds.

### Claim 12 (depends on 9)

The method according to claim 9, wherein the hydration polymer is a zwitterionic polymer, one molecular end of the zwitterionic polymer has an acrylate group, and another molecular end of the zwitterionic polymer has an anionic moiety or a cationic moiety.

### Claim 13 (depends on 12)

The method according to claim 12, wherein a number average molecular weight of the zwitterionic polymer ranges from 5000 g/mol to 10000 g/mol.

### Claim 14 (depends on 12)

The method according to claim 12, wherein the anionic moiety of the zwitterionic polymer is selected from the group consisting of a phosphate group, a sulfonic acid group, and a carboxylic acid group, and the cationic moiety of the zwitterionic polymer is a quaternary ammonium group.

### Claim 15 (depends on 12)

The method according to claim 12, wherein the zwitterionic polymer includes 2-methacryloyloxyethylphosphoric choline, sulfobetaine methacrylate, carboxybetaine methyl methacrylate, or any combination thereof.
